1
/
of
1
ELK Biotechnology
SKU:ELK8372
Human 4-Hydroxynonenal (HNE)ELISA Kit
Human 4-Hydroxynonenal (HNE)ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human 4-Hydroxynonenal (HNE)ELISA Kit
Overview
| Product name: | Human 4-Hydroxynonenal(HNE) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | 4-HNE; HNE; 4-hydroxy-2-nonenal; 4-Hydroxynonenal |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 19.1 pg/mL |
| Standard: | 2500 pg/mL |
| Range: | 39.07-2500 pg/mL |
| Sample Type: | Serum, plasma, tissue homogenates |
| Assay Length: | 2h |
| Research Area: | Signal transduction;Metabolic pathway;Infection immunity;Hormone metabolism;Dermatology; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human 4-HNE protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human 4-HNE. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human 4-HNE in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 2500.00 | 0.232 | — |
| 1250.00 | 0.336 | — |
| 625.00 | 0.583 | — |
| 312.50 | 0.993 | — |
| 156.25 | 1.225 | — |
| 78.13 | 1.596 | — |
| 39.07 | 1.877 | — |
| 0.00 | 2.325 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant 4-HNE and the recovery rates were calculated by comparing the measured value to the expected amount of 4-HNE in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 85-97% | 91% |
| EDTA plasma(n=5) | 83-95% | 89% |
| Heparin plasma(n=5) | 80-92% | 101% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of 4-HNE and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 89-97% | 85-94% | 92-102% | 81-93% |
| EDTA plasma(n=5) | 88-102% | 87-102% | 85-96% | 87-101% |
| Heparin plasma(n=5) | 87-95% | 85-96% | 92-102% | 81-92% |
Share
